Medicare utilization — DOUGLAS ALLEN SWARTZ (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | 4,560 | 25 | $0 | $84,658 |
| J9030 | Bcg live intravesical instillation, 1 mg | 2,550 | 11 | $0 | $5,751 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 1,304 | 674 | $0 | $119,716 |
| 81003 | Automated urinalysis test | 1,111 | 618 | $0 | $2,403 |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 365 | 56 | $0 | $48,097 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·